Current Covid Strain Mild, 5-6 Million Covovax Doses Made: Adar Poonawalla | Read

  • 1:07
  • Published On: April 22, 2023
Cinema View
Embed
The prevalent strain of COVID-19 is mild and the Serum Institute of India (SII) has already produced five to six million doses of the Covovax vaccine, said the company's chief executive officer Adar Poonawalla.

Related Videos

AstraZeneca Initiates A Global Withdrawal Of Its Covid-19 Vaccine
May 08, 2024 2:12
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
May 08, 2024 2:54
AstraZeneca Withdraws Covid Vaccine, Cites Commercial Reasons: Report
May 08, 2024 0:45
AstraZeneca Covid 19 Vaccine Side Effects | What Is TTS, A Rare Condition Caused By Covishield
May 01, 2024 4:03
Astrazeneca's Big U-Turn, Admits Rare Blood Clot Risk
April 30, 2024 2:21
AstraZeneca Makes Big U-Turn, Admits Covishield Can Cause Rare Side Effects
April 30, 2024 2:48
"This Was Expected": Karnataka Health Minister On JN.1 Cases In State
December 25, 2023 3:57
Maharashtra Reports 50 New COVID-19 Cases, 9 Of Them JN.1 Infections
December 25, 2023 0:46
Top Headlines Of The Day: December 24, 2023
December 24, 2023 1:20
"No Need To Panic, Need To Remain Alert": AIIMS On JN.1 Covid Variant
December 24, 2023 4:52
All You Need To Know About The New COVID Variant JN.1
December 22, 2023 9:12
21 Cases Of New Coronavirus Variant JN.1 In India Confirmed In Lab Tests
December 21, 2023 3:03
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination